IHealthScreen

AI Based Screening


EARLY IDENTIFICATION CAN SAVE YOU FROM BLINDNESS. IHEALTHSCREEN HAS CREATED ARTIFICIAL INTELLIGENCE (AI) BASED SOFTWARE TOOLS TO SCREEN AND IDENTIFY INDIVIDUALS AT RISK OF AGE-RELATED MACULAR DEGENERATION (AMD), DIABETIC RETINOPATHY (DR), AND GLAUCOMA.

DIABETIC RETINOPATHY

Diabetic Retinopathy (DR) is one of the leading causes of blindness in the world. It occurs because of the high sugar level in blood cause damage to blood vessels in the retina.

AGE-RELATED MACULAR DEGENERATION (AMD)

Age-related Macular Degeneration (AMD) is an eye disease that mostly impacts individuals of 50 years or over. The patient will characteristically develop a distinct blur the sharp central vision which needs to read, write and see clearly.

GLAUCOMA

Glaucoma often has no symptoms, and is defined by damage to the nerve that connects the eye to the brain, usually due to high eye pressure—consequently, blindness is observed in your in the surrounding vision.

Eye Conditions are expected to grow silently blinding millions of people world-wide

Diabetic Retinopathy Cases

Data Statistics
2020
2030

Macular Degeneration Cases

Data Statistics
2020
2030

Glaucoma Cases

Data Statistics
2020
2030

High Costs of Treatment

Diabetic Retinopathy Cases

$5B to $10B

Direct cost of treatment

Macular Degeneration Cases

$10B to $20B

Direct cost of treatment

Glaucoma

$4B to $8B

Direct cost of treatment

Data Statistics
Data Statistics

THE PROBLEM

BLINDNESS

Age-related macular degeneration (AMD), Diabetic Retinopathy (DR), and Glaucoma are the leading causes of blindness.

TOO LATE

There are no obvious early signs for these conditions, and often it is too late by the time patient visits an ophthalmologist.

NO TREATMENT

There is no known way to regenerate vision, which is why so early detection and preventative medicine is paramount to the mission of eradicating blindness.

LIMITED TOOLS

There are not many tools available for the early detection of these diseases.

Limitations of Current Diagnosis

There are limitations to the currently available diagnostic procedures for Age-related macular degeneration (AMD), Diabetic Retinopathy (DR), and Glaucoma. Access to specialists is not widespread, and therefore the specialist’s availability is limited. As the disease progress, the cost of the disease increases

Data Statistics

LESS
ACCESSIBLE

There are various reasons for the lack of access to specialist doctors, typically ophthalmologists, for these you. It could take days to get an appointment with some common inconveniences, including the specialist access, specialist availability, patient availability, and possibly only allotted a fixed number of images per day.

Data Statistics

TIME
CONSUMING

Traveling to and seeing the specialist can burden your schedule because of the specialist’s lack of access and flexibility in the specialist’s schedule.

Data Statistics

EXPENSIVE IF
DELAYED

As these diseases silently progress, both the cost to the body and economically increases. Early detection saves the patient from expensive treatment and disease management costs. It is estimated that 90% of Diabetic Retinopathy cases can be prevented by early detection.

Benefits of our Solution

ACCURACY

Our solution is comparable to and arguably better than an expert with >95% accuracy in screening Age-related macular degeneration (AMD) and Diabetic Retinopathy (DR).

TIMING

The entire procedure takes less than 5 minutes to image and report results.

NO SPECIALIST NECESSARY

The involvement of a specialist is not necessary unless the system refers your to the ophthalmologist.

PREVENTATIVE MEDICINE

This technology allows for large scale early detection and the intervention of preventative medicine.

Data Statistics Data Statistics